We are live on ! Find out more
TG

TCW Group Portfolio holdings

AUM $13.3B
1-Year Est. Return 34.44%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+34.44%
3 Year Est. Return
+125.95%
5 Year Est. Return
+105.75%
10 Year Est. Return
+505.62%
AUM
$12.3B
AUM Growth
+$34.7M
Cap. Flow
-$380M
Cap. Flow %
-3.08%
Top 10 Hldgs %
22.6%
Holding
381
New
24
Increased
129
Reduced
151
Closed
46

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$84.3M
2
UPS icon
United Parcel Service
UPS
+$51.1M
3
AMRX icon
Amneal Pharmaceuticals
AMRX
+$45.3M
4
NVT icon
nVent Electric
NVT
+$36.5M
5
FTI icon
TechnipFMC
FTI
+$35.9M

Top Sells

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$89.7M
2
FAST icon
Fastenal
FAST
+$71.9M
3
IPXL
Impax Laboratories, Inc.
IPXL
+$45.6M
4
SBUX icon
Starbucks
SBUX
+$35.9M
5
MSFT icon
Microsoft
MSFT
+$35M

Sector Composition

Rank Sector Weight
1 Technology 22.01%
2 Financials 20%
3 Healthcare 11.46%
4 Consumer Discretionary 11.28%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOL
376
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-223,850
Closed -$2.91M
TEN
377
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
-25,871
Closed -$1.42M
AGN
378
DELISTED
Allergan plc
AGN
-12,243
Closed -$2.06M
IPXL
379
DELISTED
Impax Laboratories, Inc.
IPXL
-2,342,835
Closed -$45.6M
MULE
380
DELISTED
MuleSoft, Inc.
MULE
-577,818
Closed -$25.4M
GGP
381
DELISTED
GGP Inc.
GGP
-548,121
Closed -$11.2M

Similar funds

TCW Group's Q2 2018 Portfolio in Review

As of Q2 2018, TCW Group held 381 positions worth $12.3B, up 0.28% from $12.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

TCW Group withdrew a net $380M in Q2 2018, closing 46 positions and reducing 151 holdings. Its most notable exit was Impax Laboratories, Inc., an estimated $45.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, TCW Group opened a new position in Amneal Pharmaceuticals worth $42.4M.

  • TCW Group's largest Q2 2018 buy was Amneal Pharmaceuticals: 2,583,162 shares worth $42.4M.
  • TCW Group added most to NVIDIA in Q2 2018, an estimated $84.3M increase.
  • TCW Group's biggest Q2 2018 reduction was Cardinal Health, cutting an estimated $89.7M.
  • TCW Group fully exited Impax Laboratories, Inc. in Q2 2018, selling an estimated $45.6M.
  • TCW Group's ten largest holdings make up 23% of its $12.3B portfolio in Q2 2018.
  • TCW Group opened 24 new positions and closed 46 in Q2 2018.
  • TCW Group's portfolio value rose 0.28% quarter-over-quarter to $12.3B.

Based on TCW Group's 13F filing for Q2 2018, filed 2 Aug 2018.